Schroder Investment Management Group’s EyePoint Pharmaceuticals EYPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.95M | Buy |
313,979
+55,994
| +22% | +$527K | ﹤0.01% | 855 |
|
|
2025
Q1 | $1.5M | Sell |
257,985
-12,351
| -5% | -$72K | ﹤0.01% | 944 |
|
|
2024
Q4 | $1.9M | Buy |
270,336
+146,403
| +118% | +$1.03M | ﹤0.01% | 933 |
|
|
2024
Q3 | $989K | Sell |
123,933
-1,189
| -1% | -$9.49K | ﹤0.01% | 1031 |
|
|
2024
Q2 | $1.09M | Sell |
125,122
-181,084
| -59% | -$1.58M | ﹤0.01% | 1016 |
|
|
2024
Q1 | $6.33M | Buy |
306,206
+126,206
| +70% | +$2.61M | 0.01% | 738 |
|
|
2023
Q4 | $4.16M | Buy |
+180,000
| New | +$4.16M | 0.01% | 802 |
|